News from annual scientific meetings around the world.
New data have shown for the first time that targeted therapy can improve the outcome…
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and…
A drug used for breast and ovarian cancer is more effective than modern targeted hormone…
A new analysis from TAILORx, the largest ever breast cancer treatment trial, has been published…
New data have shown a trend towards clinically meaningful improvements in survival and response rates…
Many new anti-cancer medicines add little value for patients compared to standard treatment and are…
A randomised clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has…
Challenging the enigmatic nature of gastro-intestinal cancers The 2019 Annual Scientific Meeting (ASM) of Australasian…
De-escalation was a major theme at the Breast Cancer Trials 41st Annual Scientific Meeting (ASM)…
Combining the PD-1 immune check point inhibitor nivolumab with the monoclonal antibody ipilimumab showed a…